Trials / Completed
CompletedNCT00139867
A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The objective of this trial was to assess subject preference for PARCOPA, carbidopa/levodopa Orally Disintegrating Tablets (ODT), compared with conventional carbidopa/levodopa tablets, in subjects with stable Parkinson's disease.
Detailed description
See approved Package Insert for Adverse Event information.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PARCOPA |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2004-05-01
- Completion
- 2004-05-01
- First posted
- 2005-08-31
- Last updated
- 2014-10-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00139867. Inclusion in this directory is not an endorsement.